巴克莱ETN+精选MLP ETNs ATMP 深 沪
已收盘 08-01 16:00:00 美东时间
29.32
-0.170
-0.58%
华盛通- 最 高29.45
- 今 开29.26
- 成交量 1.16万股
- 最 低 29.21
- 昨 收 29.49
- 总市值 5.21亿
- 52周最高 31.3915
- 市盈率 静 --
- 换手率 0.07%
- 52周最低 23.396
- 委 比 0.00%
- 总股本 1776.23万
- 历史最高 31.3915
- 量 比 2.50
- 振 幅 0.81%
- 历史最低 -0.0779
- 每 手 1
- 风险率 2.23%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Barclays Bank PLC Releases 2025 Interim Results
The latest announcement is out from Barclays ETN+ Select MLP ETN ( ($ATMP) ). B...
07-29 23:47
Barclays Modifies ETN Provisions with New Indenture
An announcement from Barclays ETN+ Select MLP ETN ( ($ATMP) ) is now available....
04-29 18:29
Ocugen aligns with FDA on confirmatory study for OCU410ST
Ocugen (NASDAQ:OCGN) said it has reached an alignment with the FDA for a Phase 2/3 pivotal confirmatory study that could be used to support a Biologics License Application for its gene therapy OCU410S...
02-27 22:54
Barclays Bank Files 2024 Annual Report with SEC
Barclays ETN+ Select MLP ETN ( ($ATMP) ) has issued an update. Barclays Bank PL...
02-14 22:57
Barclays Executes Supplemental Indenture for Debt Securities
Barclays ETN+ Select MLP ETN ( ($ATMP) ) has shared an announcement. Barclays B...
02-06 06:47
Ocugen gets positive EU opinion for ATMP classification for OCU400
Ocugen (NASDAQ:OCGN) said it has received a positive opinion from European Medicines Agency regulators for Advanced Therapy Medicinal Product classification for its gene therapy OCU400 in the treatmen...
02-04 01:25
REGENXBIO and Nippon Shinyaku Announce Exclusive Partnership to Develop and Commercialize RGX-121 and RGX-111 for MPS Diseases
REGENXBIO to receive $110 million upfront, potential milestone payments of up to $700 million and meaningful double-digit royalties on net sales, and lead manufacturing Nippon Shinyaku to le...
01-14 18:00
泽辉生物亏损加剧依赖外部研究：实验涉及伦理难题，还存对赌协议
来源：港湾商业观察 近期，泽辉生物科技有限公司（下称“泽辉生物”）赴港递交招股书，中金公司为保荐机构，国内运营主体为苏州泽辉生物科技有限公司。 ...
2024-11-21 08:20
Capricor wins key EU designations for the lead asset
Capricor Therapeutics (NASDAQ:CAPR) announced Wednesday that the European Medicines Agency has issued Orphan Drug and Advanced Therapy Medicinal Product designations for its lead asset, deramiocel. Th...
2024-11-20 23:45
Barclays ETN+ Select MLP ETN goes ex dividend tomorrow
Barclays ETN+ Select MLP ETN (BATS:ATMP) had declared $0.334/share quarterly dividend, Payable Sept. 6; for shareholders of record Aug. 28; ex-div Aug. 28. See ATMP Dividend Scorecard, Yield Chart, & ...
2024-08-28 01:11
